TCMD Straddle Strategy
TCMD (Tactile Systems Technology, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
TCMD (Tactile Systems Technology, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $683.0M, a trailing P/E of 33.66, a beta of 0.83 versus the broader market, a 52-week range of 9.415-37.77, average daily share volume of 301K, a public-listing history dating back to 2016, approximately 1K full-time employees. These structural characteristics shape how TCMD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.83 places TCMD roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on TCMD?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current TCMD snapshot
As of June 30, 2026, spot at $29.74, ATM IV 69.50%, IV rank 13.78%, expected move 19.93%. The straddle on TCMD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this straddle structure on TCMD specifically: TCMD IV at 69.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a TCMD straddle, with a market-implied 1-standard-deviation move of approximately 19.93% (roughly $5.93 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TCMD expiries trade a higher absolute premium for lower per-day decay. Position sizing on TCMD should anchor to the underlying notional of $29.74 per share and to the trader's directional view on TCMD stock.
TCMD straddle setup
The TCMD straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TCMD near $29.74, the first option leg uses a $29.74 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TCMD chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TCMD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $29.74 | N/A |
| Buy 1 | Put | $29.74 | N/A |
TCMD straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
TCMD straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on TCMD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on TCMD
Straddles on TCMD are pure-volatility plays that profit from large moves in either direction; traders typically buy TCMD straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
TCMD thesis for this straddle
The market-implied 1-standard-deviation range for TCMD extends from approximately $23.81 on the downside to $35.67 on the upside. A TCMD long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current TCMD IV rank near 13.78% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TCMD at 69.50%. As a Healthcare name, TCMD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TCMD-specific events.
TCMD straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TCMD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TCMD alongside the broader basket even when TCMD-specific fundamentals are unchanged. Always rebuild the position from current TCMD chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on TCMD?
- A straddle on TCMD is the straddle strategy applied to TCMD (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With TCMD stock trading near $29.74, the strikes shown on this page are snapped to the nearest listed TCMD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TCMD straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the TCMD straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 69.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TCMD straddle?
- The breakeven for the TCMD straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TCMD market-implied 1-standard-deviation expected move is approximately 19.93%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on TCMD?
- Straddles on TCMD are pure-volatility plays that profit from large moves in either direction; traders typically buy TCMD straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current TCMD implied volatility affect this straddle?
- TCMD ATM IV is at 69.50% with IV rank near 13.78%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.